Acclinate Logo
Talk to Our Team

A medical breach of trust is something that lingers in the minds of Black Americans. From the Tuskegee study to modern mistreatment, the racial landscape, and its repercussions, must be acknowledged and dealt with. Because the underlying issues have not been addressed, distrust is continually a fundamental reason for the lack of minority participation in clinical trials or black doctors serving black communities

Since black doctors typically get their degrees from a white system, a system designed to treat and further the healthcare of white Americans above others, it's just as hard for many of their patients to trust them any more than they do white doctors. Many black doctors have a true heart to serve their communities. Providing them with better resources that reflect their representation of the people they serve would be invaluable. 

As of late, many Black Americans are seeking out medical care from black doctors and healthcare providers. It seems the notions of "black pride" and "buy black" are moving into the medical arena as well. Although this doesn't directly address the intentional hands-off directive of the medical community at large to increase the solidarity of healthcare for all Americans, having more black medical professionals treating more black patients can raise interest for reform because let's face it, healthcare costs. Seeing those dollars go down the road to non-ethnic communities can be a true incentive for change and progress.

Another advantage to encouraging and providing access to more black professionals in healthcare is that they can help patients better understand the risks and benefits concerning clinical trials. Black Americans are grossly distrustful of human trials because of the many historically documented cases of inhumane practices. If patients can understand from their doctors and nurses how clinical trials affect healthcare issues that are more prevalent in black people, then perhaps more would come forward to participate in studies.

The bottom line is always a motivator in corporate America. The medical community is closely intertwined with corporate America. However, the real bottom line is that the medical community has a lot of explaining to do. It must redirect its focus from simply including blacks in a "business as usual" sense in healthcare to focusing on the elements that cause alarm and hesitation when it comes to blacks seeking medical care. Increased participation in valuable clinical trials can help further the cause of a healthier America, including Black America. 

To learn more about how Acclinate increases affective trust with communities of color so they are more likely to participate in clinical trials, request a consultation.

Recent Posts

For CROs, Clinical Trial Marketing Isn’t Just Support—It Is Business Development
4 Min Read

At its core, clinical research is about advancing treatments that change lives—for individuals, families, and entire communities. But those treatments...

Read More
Engaging Black and Brown Communities in Research
6 Min Read

Key Takeaways and Learnings Long-term relationship building delivers measurable results. Culturally responsive research practices require representati...

Read More
Health Tech for Inclusive Research Starts with Representation
5 Min Read

Key Takeaways and Learnings Health tech for inclusive research must be built with representation at the forefront—from design to deployment. Exclusion...

Read More
Keep Personalization Alive: Building Scalable Tech That Serves Every Community
4 Min Read

When I think about the role of technology in healthcare, I feel both excited and cautious. Excited, because scaling technology means we can reach more...

Read More
Improve Diversity in Clinical Trials Without Slowing Progress
4 Min Read

Key Takeaways and Learnings The belief that representation slows clinical trials is outdated—early inclusion strategies often speed them up. Retention...

Read More
Why Diverse Clinical Trials Yield Smarter, Safer Science
4 Min Read

Key Takeaways and Learnings Diverse clinical trials yield smarter, safer science by making results more generalizable and interventions more effective...

Read More
Turning Data Into Direction: Business Intelligence as a Catalyst for Inclusive Research
3 Min Read

I learned to respect business intelligence (BI) in hospitals and health systems, where every decision felt urgent and the stakes were always high. In ...

Read More
6 Proven Strategies for Representative Trial Recruitment
5 Min Read

Key Takeaways and Learnings One-size-fits-all efforts don’t result in inclusive participant outreach plans that work. Predictive analytics, community ...

Read More
Reduce Recruitment Risk in Pharma Through Representation
4 Min Read

Key Takeaways and Learnings Underrepresentation slows recruitment, increases dropout risk, and weakens data reliability. Proactive inclusion strategie...

Read More